Jude Onyia, Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,864 shares at $132.94 ($381K) on 2024-02-13, disclosed to the SEC on 2024-02-15.
Scheduled sale ($381k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $132.94 | 1,432 | $190K | 50.0% |
| 2 | $132.94 | 1,432 | $190K | 50.0% |
| Total | $132.94 avg | 2,864 | $381K | 100% |
| Filing → |
| NBIX | SELL | 2025-07-11 | $15.6M | — | Filing → |
| NBIX | SELL | 2025-07-07 | $5.3M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $672K | — | Filing → |